Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to ...

Did she gain the weight back? Here's what she says, plus more mindful takeaways for the reported 15 million Americans who ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

James Corden revealed that he gave Ozempic a try to help with weight loss, but soon found that his relationship with food had little to do with how hungry he was or wasn't.

Novo Nordisk has earnt yet another dressing down from the PMCPA. The U.K. | Novo Nordisk has earnt yet another dressing down ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

Despite being patented products without any approved generics, sky-high demand for GLP-1 drugs like Ozempic and Mounjaro has ...

Researchers have identified a potential new approach to address the opioid overdose epidemic. Semaglutide was shown to lower opioid overdoses in people with opioid-use disorder and type 2 diabetes.

Patients on semaglutide, the active ingredient in Ozempic and the weight-loss drug Wegovy, were less than half as likely to ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other best foreign ...